Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?

Ashraf Fayad1, Homer Yang

  • 1Department of Anesthesiology and Perioperative Medicine, University of Ottawa, 1053 Carling Ave. (B3), The Ottawa Hospital, Ottawa, Ontario, Canada, K1Y 4E9.

Current Cardiology Reviews
|November 20, 2009
PubMed

Insights

Isolated Systolic Hypertension (ISH) is a significant cardiovascular risk factor, particularly in the perioperative period. Further research is needed to understand its impact on surgical patients and improve outcomes.

Area of Science:

  • Cardiology
  • Geriatrics
  • Anesthesiology

Background:

  • Isolated Systolic Hypertension (ISH) is common in aging populations and linked to increased cardiac and cerebrovascular events.
  • ISH is associated with left ventricular (LV) changes, including hypertrophy (LVH) and diastolic dysfunction (DD).
  • Perioperative cardiac complications are a major concern, especially in lower-risk patients.

Purpose of the Study:

  • To review Isolated Systolic Hypertension (ISH) as a cardiovascular risk factor.
  • To emphasize the under-recognized role of ISH in the perioperative setting.
  • To highlight the need for further investigation into perioperative ISH.

Main Methods:

  • Literature review of Isolated Systolic Hypertension (ISH).
  • Analysis of ISH's association with cardiovascular events and LV changes.
  • Discussion of ISH in the context of perioperative cardiac complications.

Main Results:

  • ISH is the most frequent hypertension subtype (65%) in uncontrolled cases and carries higher risks than diastolic hypertension.
  • LVH and DD are common in ISH patients, increasing cardiovascular event risk.
  • Essential hypertension is not a significant perioperative risk factor in most studies, but perioperative ISH is under-studied.

Conclusions:

  • ISH is an under-recognized perioperative risk factor.
  • Further research, such as the PROMISE Study, is crucial to understand and manage perioperative ISH.
  • Managing elevated systolic blood pressure in ISH patients can reduce cardiovascular event risk.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...